Bruker Announces Acquisition of MOLECUBES NV

GHENT, Belgium--(BUSINESS WIRE)--Bruker Corporation (Nasdaq: BRKR) today announced the acquisition of MOLECUBES NV, a dynamic innovator in benchtop preclinical nuclear molecular imaging (NMI) systems. This acquisition strengthens Bruker’s position as a leading NMI solutions provider in preclinical and translational imaging research. The combination of Bruker’s preclinical imaging products and global...

Click to view original post